-
Mashup Score: 0
The role of ctDNA in disease detection and treatment selection continues to grow in importance and scope in both the metastatic and early breast cancer settings.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Pursuing Moving Targets: Assessing Target Expression to Maximize ADC Efficacy in Patients With Metastatic Breast Cancer - 2 day(s) ago
ADCs offer therapeutic promise for patients with metastatic breast cancer, with a key factor of their effectiveness being the expression of specific target antigens.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Though ADCs have emerged as a cutting-edge approach to #chemotherapy, determining when & how to assess targets in pts w/ metastatic #BreastCancer remains an evolving challenge. @YAbdouMD & @paolazagam discuss in a new editorial for #ASCODailyNews: https://t.co/3SjQWFXtfc #bcsm https://t.co/Ksnb2Ndbzq
-
-
Mashup Score: 25Updated Guideline for Advanced NSCLC With Driver Mutations Advances Roles of Osimertinib and Amivantamab + Lazertinib - 2 day(s) ago
ASCO has updated its living guideline on therapy for stage IV non–small cell lung cancer with driver mutations. These updates regard the use of osimertinib, amivantamab plus lazertinib, and other therapies in both patients who are treatment naive and in the second-line setting.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Just issued: new living guideline update on therapy for stage IV #NSCLC with driver alterations. #lungcancer For more on this updated guideline, read an in-depth analysis from #ASCODailyNews featuring insights from Expert Panel co-chair @ludabazhenovamd: https://t.co/P7cH49RKoN https://t.co/AmbqbIiYMY
-
-
Mashup Score: 4Targeting HER2 in KRAS-Mutant Metastatic CRC: How Does T-DXd Fit Into the Treatment Landscape? - 7 day(s) ago
New data from the DESTINY-CRC02 trial support the use of trastuzumab deruxtecan in HER2-positive, IHC 3+ tumors, including right-sided and KRAS-mutated tumors—a promising development in the treatment of KRAS-mutant metastatic colorectal cancer.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
RT @DrKatyMoore: https://t.co/RGYJJ9BCPt As always - so impressed by our @StephensonCC medical oncology faculty - esp my friend and Phase…
-
-
Mashup Score: 7Podcast: Advances in Immunotherapy for Melanoma and Beyond - 13 day(s) ago
Dr. Ryan Augustin and Dr. Jason Luke discuss neoadjuvant immunotherapy and the importance of multidisciplinary team coordination, the use of TIL therapy for advanced melanoma, and the emerging role of CD3 engagers in treatment strategies.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
🎙️@RyanAugustinMD of @MayoCancerCare and @jasonlukemd of @UPMCHillmanCC discuss neoadjuvant #immunotherapy and the need for multidisciplinary team coordination for pts w/ #melanoma on the latest episode of the #ASCODailyNews Podcast: https://t.co/eiKcgBW7ET #melsm https://t.co/UJ6SBDYoTO
-
-
Mashup Score: 8Podcast: Advances in Immunotherapy for Melanoma and Beyond - 14 day(s) ago
Dr. Ryan Augustin and Dr. Jason Luke discuss neoadjuvant immunotherapy and the importance of multidisciplinary team coordination, the use of TIL therapy for advanced melanoma, and the emerging role of CD3 engagers in treatment strategies.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
🎙️@RyanAugustinMD of @MayoCancerCare and @jasonlukemd of @UPMCHillmanCC discuss neoadjuvant #immunotherapy and the need for multidisciplinary team coordination for pts w/ #melanoma on the latest episode of the #ASCODailyNews Podcast: https://t.co/eiKcgBW7ET #melsm https://t.co/UJ6SBDYoTO
-
-
Mashup Score: 19Personalizing Treatment Decisions for Locally Advanced Rectal Cancer to Balance Quality of Life, Function, and Cancer Control - 16 day(s) ago
There has been a dramatic transformation of care for patients with locally advanced rectal cancer. Experts review risk stratification and therapeutic approaches with the overarching goal to better balance disease control with long-term quality of life and function.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
There has been a dramatic transformation of care for pts w locally advanced #RectalCancer w overarching goal to better balance disease control w long-term #QoL & function. Experts discuss treatments, recent trial data: https://t.co/SJSwRLUVc3 @KrishanJethwa #GICSM #ASCODailyNews https://t.co/uVt1wgStRg
-
-
Mashup Score: 5Identifying the Optimal Approach to Resectable NSCLC: Should All Patients Receive Perioperative Immunotherapy? - 19 day(s) ago
Recent regulatory approvals of ICIs in the neoadjuvant, adjuvant, and perioperative settings have changed the treatment paradigm for patients with resectable NSCLC.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
Nowadays this is probably the major issue in thoracic oncology because could impact in survival chances outcome Identifying the Optimal Approach to Resectable NSCLC: Should All Patients Receive Perioperative Immunotherapy? https://t.co/F2CrJ42GoR
-
-
Mashup Score: 17Personalizing Treatment Decisions for Locally Advanced Rectal Cancer to Balance Quality of Life, Function, and Cancer Control - 21 day(s) ago
There has been a dramatic transformation of care for patients with locally advanced rectal cancer. Experts review risk stratification and therapeutic approaches with the overarching goal to better balance disease control with long-term quality of life and function.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
There has been a dramatic transformation of care for pts w locally advanced #RectalCancer w overarching goal to better balance disease control w long-term #QoL & function. Experts discuss treatments, recent trial data: https://t.co/SJSwRLUVc3 @KrishanJethwa #GICSM #ASCODailyNews https://t.co/uVt1wgStRg
-
-
Mashup Score: 13Personalizing Treatment Decisions for Locally Advanced Rectal Cancer to Balance Quality of Life, Function, and Cancer Control - 22 day(s) ago
There has been a dramatic transformation of care for patients with locally advanced rectal cancer. Experts review risk stratification and therapeutic approaches with the overarching goal to better balance disease control with long-term quality of life and function.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
There has been a dramatic transformation of care for pts w locally advanced #RectalCancer w overarching goal to better balance disease control w long-term #QoL & function. Experts discuss treatments, recent trial data: https://t.co/SJSwRLUVc3 @KrishanJethwa #GICSM #ASCODailyNews https://t.co/uVt1wgStRg
-
ctDNA has assumed an important role in disease detection and treatment selection for metastatic and early breast cancers, and researchers are exploring how to increase its utility even further. #ASCODailyNews has more: https://t.co/iPKzpf5Qrz